Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Apr 29;2014(4):CD006134.
doi: 10.1002/14651858.CD006134.pub5.

Oral contraceptives for functional ovarian cysts

Affiliations
Meta-Analysis

Oral contraceptives for functional ovarian cysts

David A Grimes et al. Cochrane Database Syst Rev. .

Abstract

Background: Functional ovarian cysts are a common gynecological problem among women of reproductive age worldwide. When large, persistent, or painful, these cysts may require operations, sometimes resulting in removal of the ovary. Since early oral contraceptives were associated with a reduced incidence of functional ovarian cysts, many clinicians inferred that birth control pills could be used to treat cysts as well. This became a common clinical practice in the early 1970s.

Objectives: This review examined all randomized controlled trials that studied oral contraceptives as therapy for functional ovarian cysts.

Search methods: In March 2014, we searched the databases of CENTRAL, PubMed, EMBASE, and POPLINE, as well as clinical trials databases (ClinicalTrials.gov and ICTRP). We also examined the reference lists of articles. For the initial review, we wrote to authors of identified trials to seek articles we had missed.

Selection criteria: We included randomized controlled trials in any language that included oral contraceptives used for treatment and not prevention of functional ovarian cysts. Criteria for diagnosis of cysts were those used by authors of trials.

Data collection and analysis: Two authors independently abstracted data from the articles. One entered the data into RevMan and a second verified accuracy of data entry. For dichotomous outcomes, we computed the Mantel-Haenszel odds ratio with 95% confidence interval (CI). For continuous outcomes, we calculated the mean difference with 95% CI.

Main results: We identified eight randomized controlled trials from four countries; the studies included a total of 686 women. Treatment with combined oral contraceptives did not hasten resolution of functional ovarian cysts in any trial. This held true for cysts that occurred spontaneously as well as those that developed after ovulation induction. Most cysts resolved without treatment within a few cycles; persistent cysts tended to be pathological (e.g., endometrioma or para-ovarian cyst) and not physiological.

Authors' conclusions: Although widely used for treating functional ovarian cysts, combined oral contraceptives appear to be of no benefit. Watchful waiting for two or three cycles is appropriate. Should cysts persist, surgical management is often indicated.

PubMed Disclaimer

Conflict of interest statement

D Grimes has consulted with the pharmaceutical companies Bayer Healthcare Pharmaceuticals and Merck & Co, Inc.

Figures

1.1
1.1. Analysis
Comparison 1 Norethindrone 1 mg plus mestranol 50 μg daily versus expectant management, Outcome 1 Resolution of cyst within nine weeks.
2.1
2.1. Analysis
Comparison 2 Desogestrel 150 μg plus ethinyl estradiol 30 μg taken cyclically versus expectant management, Outcome 1 Resolution of cyst by last follow up (10 or 12 weeks).
3.1
3.1. Analysis
Comparison 3 Desogestrel 150 μg plus ethinyl estradiol 20 μg taken daily versus expectant management, Outcome 1 Resolution of cyst by six months.
4.1
4.1. Analysis
Comparison 4 Levonorgestrel 100 μg plus ethinyl estradiol 20 μg taken cyclically versus expectant management, Outcome 1 Resolution of cyst by 12 weeks.
5.1
5.1. Analysis
Comparison 5 Levonorgestrel 125 μg plus ethinyl estradiol 50 μg taken cyclically versus expectant management, Outcome 1 Resolution of cyst within one menstrual cycle.
6.1
6.1. Analysis
Comparison 6 Levonorgestrel 150 μg plus ethinyl estradiol 30 μg taken cyclically versus expectant management, Outcome 1 Resolution of cyst by last follow up (second or third month).
6.2
6.2. Analysis
Comparison 6 Levonorgestrel 150 μg plus ethinyl estradiol 30 μg taken cyclically versus expectant management, Outcome 2 Cyst volume after third month.
7.1
7.1. Analysis
Comparison 7 Levonorgestrel 250 μg plus ethinyl estradiol 50 μg taken cyclically versus expectant management, Outcome 1 Resolution of cyst by 10 weeks.
8.1
8.1. Analysis
Comparison 8 Levonorgestrel 50/75/125 μg plus ethinyl estradiol 30/40/30 μg taken cyclically versus expectant management, Outcome 1 Resolution of cyst by 10 weeks.
9.1
9.1. Analysis
Comparison 9 Levonorgestrel 100 μg plus ethinyl estradiol 20 μg versus desogestrel 150 μg plus ethinyl estradiol 30 μg, Outcome 1 Regression of cyst by 4 weeks.
9.2
9.2. Analysis
Comparison 9 Levonorgestrel 100 μg plus ethinyl estradiol 20 μg versus desogestrel 150 μg plus ethinyl estradiol 30 μg, Outcome 2 Regression of cyst by 12 weeks.
10.1
10.1. Analysis
Comparison 10 Levonorgestrel 100 μg plus ethinyl estradiol 20 μg versus placebo, Outcome 1 Regression of cyst by 4 weeks.
10.2
10.2. Analysis
Comparison 10 Levonorgestrel 100 μg plus ethinyl estradiol 20 μg versus placebo, Outcome 2 Regression of cyst by 12 weeks.

Update of

Comment in

Similar articles

Cited by

References

References to studies included in this review

Altinkaya 2009 {published data only}
    1. Altinkaya SO, Talas BB, Gungor T, Gulerman C. Treatment of clomiphene citrate‐related ovarian cysts in a prospective randomized study. A single center experience. Journal of Obstetrics and Gynaecology Research. 2010/02/13 2009; Vol. 35, issue 5:940‐5. - PubMed
Bayar 2005 {published data only}
    1. Bayar Ü, Barut A, Ayoğlu F. Diagnosis and management of simple ovarian cysts. International Journal of Gynecology and Obstetrics 2005;91:187‐8. - PubMed
Ben‐Ami 1993 {published data only}
    1. Ben‐Ami M, Geslevich Y, Battino S, Matilsky M, Shalev E. Management of functional ovarian cysts after induction of ovulation. A randomized prospective study. Acta Obstetricia Gynecologica Scandinavica 1993;72:396‐7. - PubMed
Kilicdag 2003 {published data only (unpublished sought but not used)}
    1. Kilicdag EB, Tarim E, Erkanli S, Aslan E, Asik G, Bagis T. How effective are ultra‐low dose contraceptive pills for treatment of benign ovarian cysts?. Fertility & Sterility 2003;80:S218‐9.
Sanersak 2006 {published data only}
    1. Sanersak S, Wattanakumtornkul S, Korsakul C. Comparison of low‐dose monophasic oral contraceptive pills and expectant management in treatment of functional ovarian cysts. Journal of the Medical Association of Thailand 2006;89:741‐7. - PubMed
Steinkampf 1990 {published data only}
    1. Steinkampf MP, Hammond KR, Blackwell RE. Hormonal treatment of functional ovarian cysts: a randomized, prospective study. Fertility and Sterility 1990;54:775‐7. - PubMed
Taskin 1996 {published data only}
    1. Taskin O, Young DC, Mangal R, Aruh I. Prevention and treatment of ovarian cysts with oral contraceptives: a prospective randomized study. Journal of Gynecologic Surgery 1996;12:21‐4.
Turan 1994 {published data only}
    1. Turan C, Zorlu CG, Ugur M, Ozcan T, Kaleli B, Gokmen O. Expectant management of functional ovarian cysts: an alternative to hormonal therapy. International Journal of Gynecology and Obstetrics 1994;47:257‐60. - PubMed

References to studies excluded from this review

Biljan 1998 {published data only}
    1. Biljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin‐releasing hormone analogues. Journal of Assisted Reproduction and Genetics 1998;15:599‐604. - PMC - PubMed
Egarter 1995 {published data only}
    1. Egarter C, Putz M, Strohmer H, Speiser P, Wenzl R, Huber J. Ovarian function during low‐dose oral contraceptive use. Contraception 1995;51:329‐33. - PubMed
Ferrero 2014 {published data only}
    1. Ferrero S, Remorgida V, Venturini P L, Leone Roberti Maggiore U. Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: A patient preference study. European Journal of Obstetrics Gynecology and Reproductive Biology 2014;174(1):117‐22. - PubMed
    1. Ferrero S, Remorgida V, Venturini P L, Leone Roberti Maggiore U. Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: A patient preference study. Fertility and Sterility 2013;100(3):S371‐2. - PubMed
Graf 1995 {published data only}
    1. Graf M, Krussel JS, Conrad M, Bielfeld P, Rudolf K. Regression of functional cysts: high dosage ovulation inhibitor and gestagen therapy has no added effect [Zur Ruckbildung funktioneller Zysten: Hochdosierte Ovulationshemmer und Gestagentherapie ohne zusatzlichen Effekt]. Geburtshilfe und Frauenheilkunde 1995;55:387‐92. - PubMed
Grimes 1994 {published data only}
    1. Grimes DA, Godwin AJ, Rubin A, Smith JA, Lacarra M. Ovulation and follicular development associated with three low‐dose oral contraceptives: a randomized controlled trial. Obstetrics and Gynecology 1994;83:29‐34. - PubMed
MacKenna 2000 {published data only}
    1. MacKenna A, Fabres C, Alam V, Morales V. Clinical management of functional ovarian cysts: a prospective and randomized study. Human Reproduction 2000;15:2567‐9. - PubMed
Muzii 2000 {published data only}
    1. Muzii L, Marana R, Caruana P, Catalano GF, Margutti, Panici PB. Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial. American Journal of Obstetrics and Gynecology 2000;183:588‐92. - PubMed
Naz 2011 {published data only}
    1. Naz T, Akhter Z, Jamal T. Oral contraceptives versus expectant treatment in the management of functional ovarian cysts. Journal of Medical Sciences 2011;19(4):185‐8.
Nezhat 1994 {published data only}
    1. Nezhat F, Nezhat CH, Borhan S, Nezhat CR. Is hormonal suppression efficacious in treating functional ovarian cysts?. Journal of the American Association of Gynecologic Laparoscopists 1994;1:S26. - PubMed
Nezhat 1996 {published data only}
    1. Nezhat CH, Nezhat F, Borhan S, Seidman DS, Nezhat CR. Is hormonal treatment efficacious in the management of ovarian cysts in women with histories of endometriosis?. Human Reproduction 1996;11:874‐7. - PubMed
Peres 1991 {published data only}
    1. Peres JAT, Baracat EC, Novo NF, Juliano Y, Lima GR. Behavior of cystic tumor of the ovary after wait‐and‐see management and hormonal treatment [Comportamento dos tumores cisticos do ovario apos conduta expectante e tratamento hormonal]. Revista Paulista de Medicina 1991;109:165‐73. - PubMed
Teichmann 1995 {published data only}
    1. Teichmann AT, Brill K, Albring M, Schnitker J, Wojtynek P, Kustra E. The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth. Gynecological Endocrinology 1995;9:299‐305. - PubMed
Young 1992 {published data only}
    1. Young RL, Snabes MC, Frank ML, Reilly M. A randomized, double‐blind, placebo‐controlled comparison of the impact of low‐dose and triphasic oral contraceptives on follicular development. American Journal of Obstetrics and Gynecology 1992;167:678‐82. - PubMed

Additional references

Anderson 1990
    1. Anderson RE, Serafini PC, Paulson RJ, Sauer MV, Marrs RP. Detection and management of pathological, non‐palpable, cystic adnexal masses. Human Reproduction 1990;5:279‐81. - PubMed
Booth 1992
    1. Booth M, Beral V, Maconochie N, Carpenter L, Scott C. A case‐control study of benign ovarian tumors. Journal of Epidemiology and Community Health 1992;46:528‐31. - PMC - PubMed
Carlsen 2001
    1. Carlsen W, Russell S. Journal retracts Stanford doctors' research articles. Co‐author admits using inaccurate data on women's surgeries in report. San Francisco Chronicle 2001 Feb 21; Vol. Sect. A:1.
Chiaffarino 1998
    1. Chiaffarino F, Parazzini F, Vecchia C, Ricci E, Crosignani PG. Oral contraceptive use and benign gynecologic conditions. Contraception 1998;57:11‐8. - PubMed
Christensen 2002
    1. Christensen J, Boldsen J, Westergaard J. Functional ovarian cysts in premenopausal and gynecologically healthy women. Contraception 2002;66:153‐7. - PubMed
ContracTech 1982
    1. Anonymous. Should OCs be prescribed to prevent adnexal masses?. Contraceptive Technology Update 1982;3:116‐8. - PubMed
Editors 2001
    1. Editors. Retraction. Surgical Laparoscopy Endoscopy and Percutaneous Techniques 2001;11:1. - PubMed
ESHRE 2001
    1. The ESHRE Capri Workshop Group. Ovarian and endometrial function during hormonal contraception. Human Reproduction 2001;16:1527‐35. - PubMed
Higgins 2008
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated Feb 2008]. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2008.
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. John Wiley & Sons, Ltd.
Holt 1992
    1. Holt VL, Daling JR, McKnight B, Moore D, Stergachis A, Weiss NS. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives. Obstetrics and Gynecology 1992;79:529‐33. - PubMed
Kozak 2005
    1. Kozak LJ, Owings MF, Hall MJ. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital and Health Statistics 2005;13 (158):1‐207. - PubMed
Lanes 1992
    1. Lanes SF, Birmann B, Walker AM, Singer S. Oral contraceptive type and functional ovarian cysts. American Journal of Obstetrics and Gynecology 1992;166:956‐61. - PubMed
Muram 1990
    1. Muram D, Gale CL, Thompson E. Functional ovarian cysts in patients cured of ovarian neoplasms. Obstetrics and Gynecology 1990;75:680‐3. - PubMed
Ory 1974
    1. Ory H, Boston Collaborative Drug Surveillance Program. Functional ovarian cysts and oral contraceptives. Negative association confirmed surgically. A cooperative study. Journal of the American Medical Association 1974;228:68‐9. - PubMed
Parazzini 1996
    1. Parazzini F, Moroni S, Negri E, Vecchia C, Dal Pino D, Ricci E. Risk factors for functional ovarian cysts. Epidemiology 1996;7:547‐9. - PubMed
Ramcharan 1981
    1. Ramcharan S, Pellegrin FA, Ray R, Hsu J‐P. Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Vol. 3, Bethesda (MD): National Institutes of Health, 1981. - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273:408‐12. - PubMed
Schulz 2002a
    1. Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet 2002;359:515‐9. - PubMed
Schulz 2002b
    1. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359:614‐8. - PubMed
Spanos 1973
    1. Spanos WJ. Preoperative hormonal therapy of cystic adnexal masses. American Journal of Obstetrics and Gynecology 1973;116:551‐6. - PubMed
Starks 1984
    1. Starks GC. Therapeutic uses of contraceptive steroids. Journal of Family Practice 1984;19:315‐21. - PubMed
Stein 1990
    1. Stein AL, Koonings PP, Schlaerth JB, Grimes DA, d'Ablaing G 3d. Relative frequency of malignant parovarian tumors: should parovarian tumors be aspirated?. Obstetrics and Gynecology 1990;75:1029‐31. - PubMed
Vessey 1987
    1. Vessey M, Metcalfe A, Wells C, McPherson K, Westhoff C, Yeates D. Ovarian neoplasms, functional ovarian cysts, and oral contraceptives. British Medical Journal 1987;294:1518‐20. - PMC - PubMed
Westhoff 1992
    1. Westhoff C, Clark CJ. Benign ovarian cysts in England and Wales and in the United States.. British Journal of Obstetrics and Gynaecology 1992;99:329‐32. - PubMed

Publication types

Substances